Terms: = Ovarian cancer AND HIP1, ILWEQ, 3092, ENSG00000127946
5 results:
1. Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.
Casanova J; Duarte GS; da Costa AG; Catarino A; Nave M; Antunes T; Serra SS; Dias SS; Abu-Rustum N; Lima J
Gynecol Oncol; 2024 Mar; 182():99-107. PubMed ID: 38262245
[TBL] [Abstract] [Full Text] [Related]
2. Recurrence, Reoperation, Pregnancy Rates, and Risk Factors for Recurrence after ovarian Endometrioma Surgery: Long-Term Follow-Up of 756 Women.
Choi SH; Kim S; Lee SW; Won S; Shim SH; Lee N; Kim MK; Jung YW; Seong SJ; Kim ML
Yonsei Med J; 2023 Mar; 64(3):204-212. PubMed ID: 36825347
[TBL] [Abstract] [Full Text] [Related]
3. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.
Mir H; Kaur G; Kapur N; Bae S; Lillard JW; Singh S
Sci Rep; 2019 Feb; 9(1):2527. PubMed ID: 30792527
[TBL] [Abstract] [Full Text] [Related]
4. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
Cuzick J; Sestak I; Baum M; Buzdar A; Howell A; Dowsett M; Forbes JF;
Lancet Oncol; 2010 Dec; 11(12):1135-41. PubMed ID: 21087898
[TBL] [Abstract] [Full Text] [Related]
5. Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.
Barbieri F; Cagnoli M; Ragni N; Foglia G; Bruzzo C; Pedullà F; Alama A
Clin Cancer Res; 1999 Jul; 5(7):1837-42. PubMed ID: 10430089
[TBL] [Abstract] [Full Text] [Related]
